Case reportA rare case of sporadic inclusion body myositis and rheumatoid arthritis exhibiting ectopic lymphoid follicle-like structures: a case report and literature review
Introduction
Sporadic inclusion body myositis (sIBM) is a degenerative, intractable, inflammatory myopathy with an immune pathomechanism [1]. sIBM develops slowly and insidiously, with 5 to 6 years elapsing between symptom onset and diagnosis; immunosuppressive therapy is usually not effective. A previous analysis of inflammatory cell composition revealed that endomysial mononuclear cells predominantly consisted of CD8+ T-cells, with few or no B-cells [2]. Although autoimmune features and coexisting autoantibodies are relatively common in sIBM [3], [4], [5], the disease has been associated with six cases of rheumatoid arthritis (RA) [6], [7], [8], [9], [10], and the clinicopathological characteristics and pathogenesis of RA-associated sIBM have not been elucidated.
In this study, we describe a patient with sIBM and subsequent RA whose muscle biopsy showed B-cell-predominant perivascular infiltration forming ectopic lymphoid follicle-like structures (ELFLSs) and sIBM pathology. We also review reports of clinical and pathological features of patients with RA-associated sIBM in the literature.
Section snippets
Case report
This study was approved by the Ethics Committee of the Tohoku University School of Medicine (No. 20774).
A 44-year-old Japanese man presented with a 4-year history of slowly progressive muscle weakness and atrophy in his hands, arms, and thighs. He was a heavy smoker, and his medical history included mild hypertension and hyperuricemia; his family history did not include any neuromuscular, cardiovascular, or autoimmune diseases. He first noticed the numbness of his left hand and difficult left
Literature review of sIBM patients with RA
Table 1 summarizes the clinical and pathological characteristics of seven sIBM patients with RA (our patient (case 1) and six from the literature [6], [7], [8], [9], [10]). The median age of sIBM onset was 53.5 years, with five male and two female patients. RA preceded sIBM in five of the six patients except for the presented case; the median age of RA onset was 41.0 years. Three patients had anti- tumor necrosis factor (TNF)α agent and MTX (cases 5–7), and four had PSL therapy (cases 2, 3, 5,
Discussion
We have described the clinicopathological features of an unusual sIBM patient who also had RA, for whom immunotherapy was partially effective. Our patient satisfied the European Neuromuscular centre IBM Research Diagnostic Criteria 2011 for clinico-pathologically defined sIBM, except for his younger age at onset (< 45 years). He had the distinct features of sIBM: selective involvement of finger flexors and quadriceps, myopathology showing CD8+ T-cell infiltration and surrounding of non-necrotic
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgment
The authors would like to thank Yayoi Aoyama, Naoko Shimakura, Yoko Tateda, Maya Narisawa and Hinako Shigihara for their excellent technical assistance, and Dr Satoshi Yamashita, Dr Nozomu Tawara and Prof Yukio Ando for the anti-NT5C1A antibody assay. The authors would also like to thank Enago (www.enago.jp) for the English language review.
This work was supported by AMED under grant number 20dk0310086, an Intramural Research Grant (20FC1036) for Neurological and Psychiatric Disorders of NCNP,
References (28)
- et al.
Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature
Semin Arthritis Rheum
(2020) - et al.
Muscle involvement in rheumatoid arthritis: clinicopathological study of 21 symptomatic cases
Semin Arthritis Rheum
(1996) - et al.
Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies
Neuromuscul Disord
(1996) - et al.
A case of mixed connective tissue disease showing a lymphoid follicle in muscle pathology
J Neurol Sci
(2003) Inclusion body myositis: clinical features and pathogenesis
Nat Rev Rheumatol
(2019)- et al.
Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis
Ann. Neurol.
(1984) - et al.
Inclusion body myositis in connective tissue disorders: case report and review of the literature
Clin Rheumatol
(2003) - et al.
Epidemiology of sporadic inclusion body myositis
Curr Opin Rheumatol
(2016) - et al.
A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review
Funct Neurol
(2013) - et al.
Inclusion body myositis in association with rheumatoid arthritis
J Rheumatol
(1994)
Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFalpha and rituximab
Clin Rheumatol
A case of inclusion body myositis responsive to prednisolone therapy
Clin Rheumatol
Inclusion body myositis in a patient with rheumatoid arthritis
Rheumatology advances in practiceRheumatol Adv Pract
Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation
Neurol Genet
Cited by (3)
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis
2023, Neuromuscular DisordersCitation Excerpt :In the present study, even though 5 patients had lymphoid aggregates with CD4+ T cell predominance over CD8+ T cell, 5 patients met at least one out of 5 sIBM classification criterion (range: 1-5 criteria; median: 3 criteria). Our literature search for myositis with prominent B cell aggregates mimicking sIBM was negative except for the single case of a 44-year-old man with finger flexor weakness, rimmed vacuoles and significant COX negative fibers on muscle pathology, and tubulofilamentous inclusions on EM yet had: 1) a myopathy responsive to treatment, 2) large, lymphoid-like aggregates at muscle pathology and 3) a diagnosis of RA on follow up (35). In fact, cases of sIBM with an associated CTD such as RA (46), SSc (47), SS (48) or SLE (49) were simply not tested for B cell aggregates.
Tertiary lymphoid structures in autoimmune diseases
2023, Frontiers in Immunology